title: Effect of treatment of overt hypothyroidism on insulin resistance.
abstract: OBJECTIVE
  To investigate the impact of hypothyroidism and thyroxine therapy on insulin sensitivity in patients with overt hypothyroidism.
  
  
  METHODS
  The study included twenty seven overtly hypothyroid and fifteen healthy euthyroid South Western Asian females. Both groups had matching age and body mass index. Physiological and pathological conditions as well as medications that may alter thyroid function, glucose homeostasis or serum lipids were ruled out. Serum thyrotropin (TSH), free tetraiodothyronine (FT4), free triiodothyronine (FT3), fasting insulin (FI), fasting plasma glucose (FPG), total cholesterol and triglycerides were measured before and six months after initiating thyroxine therapy for hypothyroid patients and once for the control group. Insulin resistance (IR) was estimated using homeostasis model assessment (HOMA-IR) and Body mass index (BMI) was calculated.
  
  
  RESULTS
  Both study groups, hypothyroid patients and euthyroid control subjects, had matching age and body mass index (P-value 0.444, 0.607 respectively). No significant difference was found between the hypothyroid patients and the euthyroid control group regarding fasting plasma glucose, fasting insulin, insulin resistance, total cholesterol and triglycerides (P-values 0.432, 0.621, 0.883, 0.586, 0.05 respectively). In the hypothyroid patients, triglycerides showed direct correlation to TSH and inverse correlation to FT3. Similarly total cholesterol inversely correlated to FT3 but its direct correlation to TSH did not reach statistical significance. After thyroxine replacement and reaching an euthyroid state as confirmed by clinical and laboratory data, there was no significant change in fasting plasma glucose, insulin resistance or triglyceride level (P-value 0.216, 0.204, 0.175 respectively) while total cholesterol significantly decreased (P-value 0.043) and fasting insulin significantly increased (P-value 0.047).
  
  
  CONCLUSIONS
  Hypothyroidism has no impact on insulin sensitivity. Correction of hypothyroidism is not associated with a significant change of insulin sensitivity or triglycerides, but with a significant reduction of total cholesterol.
authors: Aml Mohamed Nada, Department of Internal Medicine, Unit of Endocrinology, Diabetes and Metabolism, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
authors: Aml Mohamed
authors: AM
authors: Nada
keywords: Cholesterol; Female; Hypothyroidism; Insulin resistance; Thyroxine; Triglycerides
references: Clin Chim Acta. 1998 Jul 6;275(1):81-91
references: 9706846
references: Eur J Endocrinol. 2005 Jul;153(1):73-9
references: 15994748
references: Thyroid. 2004 Jun;14(6):443-6
references: 15242571
references: Int J Clin Pract. 2010 Jul;64(8):1130-9
references: 20642711
references: Metabolism. 1997 Feb;46(2):154-8
references: 9030821
references: Clin Chem. 1996 Jan;42(1):135-9
references: 8565215
references: J Clin Endocrinol Metab. 2007 Feb;92(2):608-11
references: 17148561
references: Diabetologia. 1985 Jul;28(7):412-9
references: 3899825
references: J Nepal Health Res Counc. 2011 Apr;9(1):33-7
references: 22929710
references: Clin Endocrinol (Oxf). 1997 Jan;46(1):17-20
references: 9059553
references: Metabolism. 1995 Dec;44(12):1559-63
references: 8786724
references: Arch Physiol Biochem. 1999 Oct;107(4):273-9
references: 10779823
references: Pflugers Arch. 2001 Aug;442(5):662-7
references: 11512021
references: Med Clin North Am. 2012 Mar;96(2):269-81
references: 22443975
references: Diabetes. 1990 Jun;39(6):647-52
references: 2189759
references: Clin Endocrinol (Oxf). 2008 Dec;69(6):963-9
references: 18429948
references: Med Sci Monit. 2007 Jan;13(1):RA12-7
references: 17179917
references: Clin Nutr. 1999 Oct;18(5):319-22
references: 10601541
references: Thyroid. 2000 Sep;10(9):803-8
references: 11041458
references: J Clin Endocrinol Metab. 1995 Feb;80(2):562-6
references: 7852521
references: Am J Clin Nutr. 2000 Sep;72(3):694-701
references: 10966886
references: Clin Sci (Lond). 2003 Jan;104(1):7-15
references: 12519082
references: J Pharmacol Pharmacother. 2012 Apr;3(2):156-60
references: 22629091
references: Acta Clin Belg. 2006 Mar-Apr;61(2):69-73
references: 16792337
references: Diabet Med. 1995 Jul;12(7):622-7
references: 7554786
references: Q J Med. 1986 May;59(229):513-21
references: 3763814
references: Acta Physiol Pharmacol Latinoam. 1985;35(2):181-91
references: 2938405
references: J Clin Endocrinol Metab. 1993 Jan;76(1):121-6
references: 8421075
references: Mol Cell Endocrinol. 1997 Apr 4;128(1-2):97-102
references: 9140080
references: Thyroid. 2008 Feb;18(2):227-37
references: 18279023
references: Mayo Clin Proc. 1998 Sep;73(9):837-41
references: 9737219
references: J Clin Invest. 1974 Nov;54(5):1107-24
references: 4370795
references: Int J Obes Relat Metab Disord. 2001 Mar;25(3):417-25
references: 11319641
references: Transl Res. 2008 Apr;151(4):224-31
references: 18355770
references: Eur J Endocrinol. 2010 Sep;163(3):427-34
references: 20566590
references: Metabolism. 1992 Aug;41(8):911-4
references: 1386404
references: Eur J Clin Invest. 1993 Sep;23(9):585-8
references: 8243531
references: Clin Chem Lab Med. 2005;43(7):715-20
references: 16207130
references: Thyroid. 2007 May;17(5):453-60
references: 17542675
references: J Lipid Res. 1981 Feb;22(2):307-22
references: 7240960